LANSING, Mich., Feb. 13 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) has expanded its line of products developed for the dairy industry to include the quickest test available for tetracycline residues in milk. The tetracyclines group of dairy antibiotics is used to treat bovine mastitis, and includes tetracycline, chlortetracycline, and oxytetracycline.
Neogen's new TetraStar(R) dairy antibiotic test for tetracyclines complements the company's widely used BetaStar(R) test for the beta-lactam group of dairy antibiotics, which includes amoxicillin, ampicillin, cephapirin, cloxacillin, and penicillin. TetraStar produces clear results in a market-best six minutes, and like BetaStar, is an extremely simple dipstick test that requires only minimal training and equipment to produce consistently accurate results.
"As tetracyclines have emerged as a second choice of antibiotics to beta- lactams for the management of mastitis in dairy herds in certain regions of the world, the concern over tetracycline drug residues in milk has grown," said Lon Bohannon, Neogen's president. "Developing TetraStar allows us to offer the worldwide dairy industry yet another simple solution to protect its consumers and businesses. Two years ago when we acquired the dairy antibiotics business from UCB, including its popular BetaStar line, we did so with the idea of expanding the business by introducing new products based on market demand. Launching TetraStar today is yet another example of our commitment to supply innovative products to help meet our customers' needs."
Because the tetracyclines group of dairy antibiotics is not yet used as
universally as the beta-lactam group, regulations governing the maximum
allowable levels of tetr
|SOURCE Neogen Corporation|
Copyright©2008 PR Newswire.
All rights reserved